Guru Ownership Trend
Guru Analysis for AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $38.31 M.
Top institutional holders include Paul Tudor Jones and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $19.33 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 34.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for AbCellera Biologics Inc. (ABCL)
Major holders include Paul Tudor Jones ($16.2 M), Renaissance Technologies (RenTech) ($7.78 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 3.05 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $19.33 M, with 0 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited ABCL. The total reported sell value was $19.33 M.
No tracked managers opened new positions or increased their holdings in ABCL during the most recent reporting period.